openPR Logo
Press release

Comprehensive Study on Facial Injectable Market 2018 – 2026 by Application, Segments and Key Players Analysis: Allergan, Sanofi, Advanced Dermatology, Galderma Laboratories, Anika Therapeutics

11-21-2018 02:36 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Facial Injectable Market

Facial Injectable Market

Facial Injectable Market is anticipated to reach over USD 18,819.04 Million by 2026 according to a new research published by Polaris Market Research.

Factors such as the rise in demand to augment the visual look and growing popularity for negligibly intrusive procedures majorly drive the Facial Injectable Market. In addition, the rise in elderly population and introduction of improved facial injectable such as synthetic calcium hydroxyl apatite fillers further anticipated boosting the market growth.

For more Professional and Technical Insights Request Sample @
https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/request-for-free-sample

Facial injectable products also called as dermal fillers are products that benefit in facial transformation. These facial injectable products are widely used to indulgence the early signs of age as well as wrinkles thereby increasing the visual attractiveness.

In recent time, growing demand for non-surgical processes for facial transformation and modification is gaining global admiration. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, non-surgical and surgical cosmetic techniques showed an overall rise of 9% from past years. Moreover, according to the same report in 2016, nonsurgical procedures including injectable accounted for approximately 8 million globally.

Some major key players in Facial Injectable Market include: -
• Advanced Dermatology
• Merz Inc.
• Galderma Laboratories
• ColBar LifeScience Ltd.
• Allergan Plc.
• Valeant Pharmaceuticals North America LLC.
• Sanofi Biosurgery Inc. (Sanofi)
• Anika Therapeutics Inc.
• Suneva Medical Inc.

Key players are adopting partnerships and product introduction strategies in order to fulfil the unmet aesthetic as well as clinical needs thus, providing surgeons with better and novel options further augmenting the growth of the Facial Injectable Market. For instance, in 2017, the company Galderma collaborated with Colorescience to expand its skincare solutions for persons that can be used in combination with orthodox facial injectable aesthetic treatments.

Make an Enquiry for 'Queries' related to this research report @
https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market/inquire-before-buying

Facial Injectable Market is segmented on the basis of products, end users: -
On the basis of products, the Global Facial Injectable Market is segmented into Dermal Fillers/Injectable Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the basis of products, the hyaluronic acid segment is estimated to dominate the market in 2017.

Moreover, this segment is anticipated to show lucrative growth during the forecast period. Cumulative use of hyaluronic acid as a dermal filler in the cosmetic procedure is anticipated to support the market growth. Hyaluronic acid has become an important part of cosmetics and aesthetic surgeries due to its robust water retaining properties. In general, the cosmetic-grade hyaluronic acid has the lower molecular weight which further aids to retain water in the cells, releases antioxidants, form the deep penetration of the product in the epidermis, and delays the aging progression.

On the basis of the end user, Facial Injectable Market is segmented into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes. In 2017, hospital segment is estimated to dominate the global market.

Partial TOC of Facial Injectable Market: -

1. Industry snapshot
2. Ecosystem analysis
3. Market Dynamics
4. Industry analysis - Porter's five force
5. Degree of competition
6. Market PEST Analysis
7. Market Value Chain Analysis
8. Industry Trends
9. Competitive Ranking Analysis

Related Report : http://www.sbwire.com/press-releases/orthopedic-implants-market-estimated-at-65583mn-by-2025-and-cagr-of-484-medtronic-plc-zimmer-biomet-holdings-smith-nephew-plc-stryker-corporation-nuvasive-1085202.htm

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Comprehensive Study on Facial Injectable Market 2018 – 2026 by Application, Segments and Key Players Analysis: Allergan, Sanofi, Advanced Dermatology, Galderma Laboratories, Anika Therapeutics here

News-ID: 1389494 • Views:

More Releases from Polaris Market Research & Consulting

Agricultural Lighting Market Witness Exponential Growth USD 33,158.07 Million With an Excellent CAGR of 12.40% by 2032
Agricultural Lighting Market Witness Exponential Growth USD 33,158.07 Million Wi …
𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐫𝐞𝐜𝐞𝐧𝐭𝐥𝐲 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐢𝐭𝐬 𝐥𝐚𝐭𝐞𝐬𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 𝐭𝐢𝐭𝐥𝐞𝐝 "𝐀𝐠𝐫𝐢𝐜𝐮𝐥𝐭𝐮𝐫𝐚𝐥 𝐋𝐢𝐠𝐡𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠 (𝐇𝐚𝐫𝐝𝐰𝐚𝐫𝐞, 𝐒𝐨𝐟𝐭𝐰𝐚𝐫𝐞, 𝐚𝐧𝐝 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬), 𝐋𝐢𝐠𝐡𝐭 𝐒𝐨𝐮𝐫𝐜𝐞, 𝐖𝐚𝐭𝐭𝐚𝐠𝐞, 𝐈𝐧𝐬𝐭𝐚𝐥𝐥𝐚𝐭𝐢𝐨𝐧 𝐓𝐲𝐩𝐞, 𝐒𝐚𝐥𝐞𝐬 𝐂𝐡𝐚𝐧𝐧𝐞𝐥, 𝐑𝐞𝐠𝐢𝐨𝐧 - 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 2032." 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 11800.22 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023. 𝐓𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 33,158.07 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 12.40% 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞
Directed Energy Weapons Market: Exploring the Projected USD 22.10 Billion Industry Size by 2032
Directed Energy Weapons Market: Exploring the Projected USD 22.10 Billion Indust …
Governments from various countries are toiling to handle the growing requirement for manifold security solicitations by incorporating directed energy technology into their military applications. Our thorough analysis of the Directed Energy Weapons Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments. 𝐓𝐡𝐞 𝐃𝐢𝐫𝐞𝐜𝐭𝐞𝐝 𝐄𝐧𝐞𝐫𝐠𝐲 𝐖𝐞𝐚𝐩𝐨𝐧𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 • Market Size: The global market for directed energy weapons was valued
Heavy Construction Equipment Market Projected to Hit US$ 298.24 Billion by 2032, to grow at a CAGR of 4.40% | PMR
Heavy Construction Equipment Market Projected to Hit US$ 298.24 Billion by 2032, …
The global Heavy Construction Equipment Market was valued at USD 202.95 billion in 2023 to USD 298.24 billion by 2032, disclosing a CAGR of 4.40% during the forecast period of 2024-2032. According to a new market research report published by Polaris Market Research, the global Heavy Construction Equipment Market is expected to grow at a CAGR of 4.40% from 2024 to 2032. The growing usage of heavy construction equipment by several
Communication Platform As A Service Market Set for Strong Growth at 31.0% CAGR, Reaching USD 172.91 Billion By 2032
Communication Platform As A Service Market Set for Strong Growth at 31.0% CAGR, …
Polaris Market Research has recently published its latest research report titled "Communication Platform As A Service Market by Component (Solutions (Voice, Message, and Video) and Services (Professional and Managed)), Organization Size, Region - Global Forecast to 2032." The research report reveals that the market was valued at USD 15.24 billion in 2023. The industry is projected to grow to USD 172.91 billion by 2032, exhibiting a CAGR of 31.0% over

All 5 Releases


More Releases for Injectable

Injectable Sumatriptan Market 2021 | Detailed Report
ReportsnReports publishes the report titled Injectable Sumatriptan that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Global Injectable Drug Delivery Market to 2028 |Retail Pharmacies, Injectable Dr …
Market Research Hub (MRH) has carefully analyzed this research study titled Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Injectable Drug Delivery. Readers can gain knowledge related to prime
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of